APOTEA: Q3 revenue up 12.5%, adjusted EBIT margin at 5.4%
APOTEA reported third-quarter revenue up 12.5% year on year to SEK 1,990 million, with a 5.4% adjusted EBIT margin, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, APOTEA's revenue in the third quarter grew 12.5% year on year to SEK 1,990 million. The adjusted EBIT margin came in at 5.4%.
The results were supported by growth in RX products, efficiency gains at the Varberg site and an early ramp-up in Norway. The company expects capital expenditure for 2027 of SEK 50–75 million.
why it matters
For the market, the combination of revenue growth and a higher margin matters: it points to improving profitability, not only bigger volumes. The capex guidance helps gauge the company's future cash flow.
market impact
APOTEA shares: revenue growth and higher margin support the stock
- APOTEA shares pressure up — revenue growth and margin expansion point to higher profitability
tags
instruments
sources
- APOTEA: Q3 revenue grew 12.5%, with adjusted EBIT margin at 5.4% — TradingView, 5 November 2026 at 10:28 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗